Endo cuts 2012 forecast on poor Opana sales; Hungary's Richter hikes its expectations;

@FiercePharma: Congressional hearings on the meningitis debacle to begin next week. FDA's Hamburg on the sked: Report | Follow @FiercePharma

> Endo Health Solutions ($ENDP) failed to deliver on third-quarter revenue, as lower sales of its pain drug Opana ER fell short; the company cut its 2012 outlook for the second time in two months. Report

> Hungary's Richter raised its 2012 growth forecast to 3%, after previously predicting flat sales for the year; margins are still expected to drop from 2011. Report

> India's Cipla reported strong growth for the first half of its fiscal year, but analysts worry that it may not continue. Report

> AMAG Pharmaceuticals said its partner Takeda has launched its anemia drug Rienso in Europe; it's sold as Feraheme in the U.S. Report

> AFK Sistema may buy a controlling interest in Russia's VeroPharm from the troubled pharmacy chain 36.6. Report

Medical Device News

 @FierceMedDev: After another quarterly slide, Wright Medical is planning to reorganize. Report | Follow @FierceMedDev

 @MarkHFierce: FDA warns the maker of a light therapy product designed to treat fungal meningitis that the product is unapproved. More | Follow @MarkHFierce

 @DamianFierce: Myriad Genetics is raising its full-year guidance after a strong quarter. More | Follow @DamianFierce

> FDA cites Tennessee company for meningitis light therapy device. Item

> St. Jude chases renal denervation market share with new study. Report

Biotech News

 @FierceBiotech: From FierceVaccines.com: PsiOxus lands $2.7M for ovarian cancer vaccine trial. Item | Follow @FierceBiotech

 @JohnCFierce: Buyout Buzz: The most frequently cited takeover targets in biotech. Special Report | Follow @JohnCFierce

 @RyanMFierce: Crowdsourcing kick spurs interest in NIH drug recycling. More | Follow @RyanMFierce

> PCSK9 rivals Amgen and Pfizer angle for AHA spotlight with promising data. Story

> Takeda snaps up CNS drug developer Envoy Therapeutics in $140M deal. News

> Ambit Biosciences finds $50M more from VCs as leukemia therapy advances. Article

Biotech Research News

> Failed AstraZeneca drugs gain second chance with $11M U.K. program. News

> UC Davis team finds new lung cancer Rx target. Article

> 'Abdominal imaging window' lets researchers crack cancer metastasis secrets. Story

> Scientists wield stem cells to undo male infertility inflicted by cancer treatment in monkeys. More

Pharma Manufacturing News

> India's price-setting agency prepares for plant inspections. Story

> Sigma-Aldrich gets foothold in S. Korea with API deal. Article

> German Bayer partners with Russian drug manufacturer. News

And Finally... Daily multivitamins didn't cut men's risk of heart attack in a long-term study. Report